Credit: ©2020 Du et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20191115
Compared with a control (left), treatment with the drug MK2206 (right) reduces the levels of PD-L1 (brown) in glioblastoma cells in mice.